| Description | Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease. |
| Synonyms | (R)-NPT200-11, UCB0599, DLX-313 |
| molecular weight | 425.59 |
| Molecular formula | C23H31N5OS |
| CAS | 1802518-92-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Price DL,et al. In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease. NPJ Parkinsons Dis. 2023 Jul 17;9(1):114. |